SRI International

AI Poised to Transform Pharmaceutical Industry with $208 Billion Investment by 2030

7 months ago

• The pharmaceutical sector is projected to invest over $208 billion in AI technologies by 2030, marking a significant shift in drug development and clinical research processes. • Integration of AI with wearable technologies, electronic health records, and medical devices is enabling real-time patient monitoring and more efficient clinical trials. • Despite rapid AI adoption in healthcare, nearly 50% of pharmaceutical executives report a shortage of skilled AI professionals, highlighting critical workforce development needs.